MDM4 and neoplasm: The ultimate capacity of the tumours to overcome the inhibitory effects of MDM4 KD, however, predicts that additional events were selected in vivo to circumvent the inhibitory impact of MDM4 KD (where MDM4 KD is maintained at end point in these tumours Figure 4d).